{"webUser":null}

MS News & Perspectives / Tolebrutinib Trials Paused Over Safety Concerns & Setback for MS Spasticity Treatment

View our embed guidelines

Sorry, your browser isn't supported.

We recommend upgrading to the latest Chrome, Firefox, Safari, or Edge.

You can visit our support center if you're having problems.